“While the term ‘Ozempic Butt’ may be new, the concept of being left with sagging skin after rapidly losing a large amount of ...

Legal battle over Novo Nordisk's semaglutide drug in India, with DRL, raises concerns over patent infringement and drug ...

A doctor has explained why Ozempic use has her 'fearing for society' as she pointed out one problem with people taking the drug.

The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

It is the biggest shake-up of obesity treatment in NHS history, it has been claimed. From later this month, GPs will be able ...